Evidence map›Paper›PMID 34082509›Full record

ArticleMolecular imaging and radionuclide therapy2021

Correlation of

Zümrüt Arda Kaymak, Nermin Karahan, Mehmet Erdoğan, Evrim Erdemoğlu, İsmail Zihni, Sevim Süreyya Şengül

Open access · diamondAbstract read
In one paragraph

Article in Molecular imaging and radionuclide therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Predictive role of [EJNMMI reports · 2024
    Article
  4. Does high [European radiology · 2023
    Article
  5. Oncology letters · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zümrüt Arda KaymakSüleyman Demirel University Faculty of Medicine, Department of Radiaiton Oncology, Isparta, TurkeyORCID 0000-0002-7284-008X
Nermin KarahanSüleyman Demirel University Faculty of Medicine, Department of Pathology, Isparta, TurkeyORCID 0000-0003-0883-4037
Mehmet ErdoğanSüleyman Demirel University Faculty of Medicine, Department of Nuclear Medicine, Isparta, TurkeyORCID 0000-0001-7724-778X
Evrim ErdemoğluSüleyman Demirel University Faculty of Medicine, Department of Gynecologic Oncology, Isparta, TurkeyORCID 0000-0002-5993-6968
İsmail ZihniSüleyman Demirel University Faculty of Medicine, Department of Surgical Oncology, Isparta, TurkeyORCID 0000-0002-2133-2106
Sevim Süreyya ŞengülSüleyman Demirel University Faculty of Medicine, Department of Nuclear Medicine, Isparta, TurkeyORCID 0000-0003-0391-5428
Süleyman Demirel University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Post-hypoxia hypoxia-inducible factor (HIF)-1α activation plays a vital role in colorectal cancer (CRC) angiogenesis. Although glucose metabolism is induced in some cancer types via HIF-1α, the prognostic significance of HIF-1α in CRC and its correlation with Methods: Thirty-six histopathologically confirmed patients with CRC who had Results: The tumor location, tumor diameter, perineural invasion, lymphovascular invasion, T and N stage were not significantly correlated with HIF-1α overexpression. In contrast, the tumor differentiation was negatively correlated with HIF-1α expression (r=-0.332, p=0.048). None of the Conclusion: The expected association between HIF-1α overexpression and

Indexed as

18F-FDG/PET/CTcolorectal cancerHypoxia-inducible factor-1αMTVTLG

Identifiers

PMID34082509
PMCPMC8185477
OpenAlexW3165725123

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.